Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction

Regenerative Medicine

Volumn 7, Issue 4, 2012, Pages 523-533

  Chiu, Loraine L Y ^a   Reis, Lewis A ^b   Momen, Abdul ^c   Radisic, Milica ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

angiogenesis; encapsulation; hydrogel; myocardial infarction; thymosin 4

Indexed keywords

BLOOD CLOTTING FACTOR 8; CHITOSAN; COLLAGEN; PROTEIN KINASE B; THYMOSIN BETA4;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG RESPONSE; ENZYME ACTIVITY; HEART INFARCTION; HYDROGEL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD VESSELS; CHITOSAN; COLLAGEN; DELAYED-ACTION PREPARATIONS; FACTOR VIII; HYDROGELS; INJECTIONS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED LEW; STAINING AND LABELING; THYMOSIN;

EID: 84864255093     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.12.35     Document Type: Article

References (30)

1. Wang F, Guan J. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv. Drug Deliv. Rev. 62(7-8), 784-797 (2010).
2. Rane AA, Chuang JS, Shah A et al. Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction. PLoS One 6(6), e21571 (2011).
3. Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl Acad. Sci. USA 98(18), 10344-10349 (2001). (Pubitemid 32803022)
4. Zhang G, Hu Q, Braunlin EA, Suggs LJ, Zhang J. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Eng. Part A 14(6), 1025-1036 (2008). (Pubitemid 351862226)
5. Rufaihah AJ, Haider HK, Heng BC et al. Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair. Regen. Med. 5(2), 231-244 (2010).
6. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 10(3-4), 403-409 (2004). (Pubitemid 38580261)
7. Huang NF, Yu J, Sievers R, Li S, Lee RJ. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng. 11(11-12), 1860-1866 (2005). (Pubitemid 43120198)
8. Leor J, Tuvia S, Guetta V et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine. J. Am. Coll. Cardiol. 54(11), 1014-1023 (2009).
9. Singelyn JM, Sundaramurthy P, Johnson TD et al. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J. Am. Coll. Cardiol. 59(8), 751-763 (2012).
10. Wu J, Zeng F, Huang XP et al. Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Biomaterials 32(2), 579-586 (2011).
11. Bocchi L, Savi M, Graiani G et al. Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. PLoS One 6(3), e17750 (2011).
12. Ruvinov E, Leor J, Cohen S. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials 31(16), 4573-4582 (2010).
13. Lu WN, Lu SH, Wang HB et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng. Part A 15(6), 1437-1447 (2009).
14. Deng C, Zhang P, Vulesevic B et al. A collagen-chitosan hydrogel for endothelial differentiation and angiogenesis. Tissue Eng. Part A 16(10), 3099-3109 (2010).
15. Shrivastava S, Srivastava D, Olson EN, Dimaio JM, Bock-Marquette I. Thymosin beta4 and cardiac repair. Ann. NY Acad. Sci. 1194, 87-96 (2010).
16. Smart N, Bollini S, Dube KN et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature 474(7353), 640-644 (2011).
17. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432(7016), 466-472 (2004). (Pubitemid 39576522)
18. Chiu LL, Radisic M. Controlled release of thymosin beta4 using collagen-chitosan composite hydrogels promotes epicardial cell migration and angiogenesis. J. Control Release 155(3), 376-385 (2011).
19. Zaidi SH, Huang Q, Momen A, Riazi A, Husain M. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction. J. Am. Coll. Cardiol. 55(2), 135-143 (2010).
20. Hoefer J, Azam MA, Kroetsch JT et al. Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction. Circ. Res. 107(7), 923-933 (2010).
21. Sauve M, Ban K, Momen MA et al. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice. Diabetes 59(4), 1063-1073 (2010).
22. Miyagi Y, Zeng F, Huang XP et al. Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. Biomaterials 31(30), 7684-7694 (2010).
23. Mann DL. Mechanisms and models in heart failure: A combinatorial approach. Circulation 100(9), 999-1008 (1999). (Pubitemid 29407182)
24. Liao Sy, Siu CW, Liu Y et al. Attenuation of left ventricular adverse remodeling with epicardial patching after myocardial infarction. J. Card. Fail. 16(7), 590-598 (2010).
25. Wang T, Wu DQ, Jiang XJ et al. Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling. Eur. J. Heart Fail. 11(1), 14-19 (2009).
26. Ifkovits JL, Tous E, Minakawa M et al. Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc. Natl Acad. Sci. USA 107(25), 11507-11512 (2010).
27. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44(3), 654-660 (2004). (Pubitemid 39089073)
28. Srivastava D, Saxena A, Michael Dimaio J, Bock-Marquette I. Thymosin beta4 is cardioprotective after myocardial infarction. Ann. NY Acad. Sci. 1112, 161-170 (2007). (Pubitemid 47598683)
29. Smart N, Risebro CA, Melville AA et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445(7124), 177-182 (2007). (Pubitemid 46095717)
30. Kraehenbuehl TP, Ferreira LS, Hayward AM et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 32(4), 1102-1109 (2011).